Botanix Pharmaceuticals Limited (ASX:BOT)
Australia · Delayed Price · Currency is AUD 0.0200
+0.0010 (5.26%)
Sep 11, 2026, 12:04 PM AEST
Botanix Pharmaceuticals Cash Flow Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Operating Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Net Income | -69.77 | -86.4 | -13.87 | -9.15 | -13.17 |
Depreciation & Amortization | 2.32 | 2.26 | 0.07 | 0.11 | 0.14 |
Other Amortization | 2.45 | 5.11 | - | - | - |
Stock-Based Compensation | 10.41 | 20.52 | 4.39 | 1.52 | 0.33 |
Other Operating Activities | -1.59 | 0.06 | - | -0 | - |
Change in Accounts Receivable | -5.34 | -4.16 | -2.34 | -0.41 | -0.1 |
Change in Inventory | -4.95 | -26.87 | 1.68 | -0.1 | -3.04 |
Change in Accounts Payable | 1.86 | 10.88 | 1.94 | -4.04 | 4.65 |
Operating Cash Flow | -64.6 | -78.58 | -8.13 | -12.07 | -11.18 |
Operating Cash Flow Growth | - | - | - | - | - |
Investing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Capital Expenditures | - | -0.29 | -0.11 | -0.01 | -0.01 |
Sale (Purchase) of Intangibles | - | -0.76 | -17.89 | -7.05 | -2.91 |
Other Investing Activities | -0.41 | - | - | - | - |
Investing Cash Flow | -0.41 | -1.05 | -18 | -7.05 | -2.92 |
Financing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Short-Term Debt Issued | - | 28.4 | - | 1.85 | - |
Total Debt Issued | - | 28.4 | - | 1.85 | - |
Short-Term Debt Repaid | - | - | - | -1.85 | - |
Long-Term Debt Repaid | -3.02 | -0.19 | - | -0.12 | -0.15 |
Lease Payments | -0.26 | -0.19 | - | -0.12 | -0.15 |
Total Debt Repaid | -3.02 | -0.19 | - | -1.97 | -0.15 |
Net Debt Issued (Repaid) | -3.02 | 28.2 | - | -0.12 | -0.15 |
Issuance of Common Stock | 45.02 | 40.46 | 100.85 | 23.59 | - |
Other Financing Activities | -5.42 | -3.31 | -5.76 | -1.44 | - |
Financing Cash Flow | 36.58 | 65.36 | 95.1 | 22.03 | -0.15 |
Net Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Foreign Exchange Rate Adjustments | 0.09 | -0.06 | 0.09 | 0.06 | -0.01 |
Net Cash Flow | -28.34 | -14.34 | 69.06 | 2.96 | -14.27 |
Free Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Free Cash Flow | -64.6 | -78.87 | -8.24 | -12.08 | -11.19 |
Free Cash Flow Growth | - | - | - | - | - |
Free Cash Flow Margin | -191.10% | -1362.39% | -398.17% | -320.27% | -406.24% |
Free Cash Flow Per Share | -0.03 | -0.04 | -0.01 | -0.01 | -0.01 |
Levered Free Cash Flow | -32.94 | -38.58 | -20.3 | -15.57 | -9 |
Unlevered Free Cash Flow | -33.62 | -40.34 | -20.3 | -15.52 | -8.97 |
Free Cash Flow After Leases | -64.86 | -79.06 | -8.24 | -12.2 | -11.34 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Cash Interest Paid | 2.64 | 0.05 | - | 0.08 | 0.04 |
Cash Income Tax Paid | - | -1.5 | - | -3.67 | -2.75 |
Change in Working Capital | -8.42 | -20.14 | 1.28 | -4.55 | 1.51 |